TRIAMINIC EXPECTORANT DH SYRUP Sirop

Country: Կանադա

language: ֆրանսերեն

source: Health Canada

active_ingredient:

Chlorhydrate de phénylpropanolamine; Maléate de phéniramine; Maléate de pyrilamine; Guaïfénésine; Bitartrate d'hydrocodone

MAH:

NOVARTIS CONSUMER HEALTH CANADA INC.

ATC_code:

R05FA02

INN:

OPIUM DERIVATIVES AND EXPECTORANTS

dosage:

12.5MG; 6.25MG; 6.25MG; 100MG; 1.67MG

pharmaceutical_form:

Sirop

composition:

Chlorhydrate de phénylpropanolamine 12.5MG; Maléate de phéniramine 6.25MG; Maléate de pyrilamine 6.25MG; Guaïfénésine 100MG; Bitartrate d'hydrocodone 1.67MG

administration_route:

Orale

units_in_package:

500ML

prescription_type:

Stupéfiant (LRCDAS I)

therapeutic_area:

ANTITUSSIVES

leaflet_short:

Numéro de groupe d'ingrédients actifs (GIA) :0503200001; AHFS:

authorization_status:

ANNULÉ APRÈS COMMERCIALISATION

authorization_date:

2001-04-06